Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000513923 | SCV000611072 | likely benign | not provided | 2017-08-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316464 | SCV000849749 | likely benign | Inborn genetic diseases | 2017-05-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001089026 | SCV001131924 | likely benign | KBG syndrome | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000513923 | SCV001890787 | benign | not provided | 2021-01-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001089026 | SCV002524177 | benign | KBG syndrome | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003925531 | SCV004738299 | likely benign | ANKRD11-related condition | 2024-01-20 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |